Overview Money In Money Out People Audits Positions Interview Endorsements
About TB alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.
In care of Angela Vanderploeg
Donations are tax-deductible
Financial Snapshot FY ending 2023-12-31 Financial history 17 18 19 20 21 22 23
Latest FY2023: $60.2M · Peak FY2019: $174.9M · Avg: $82.5M
Foreign activity (Schedule F) Total spent abroad $19.3M
Foreign employees 43
Foreign offices 1
Foreign partnership interest No
Foreign trust interest No
Region Activity Spent East Asia and the Pacific — — East Asia and the Pacific — — East Asia and the Pacific — — East Asia and the Pacific — — Europe (Including Iceland and Greenland) — — Europe (Including Iceland and Greenland) — — Europe (Including Iceland and Greenland) — — Europe (Including Iceland and Greenland) — — Middle East and North Africa — — Middle East and North Africa — — North America — — North America — — North America — — Russia and the Newly Independent States — — Russia and the Newly Independent States — — Russia and the Newly Independent States — — Russia and the Newly Independent States — — South America — — South America — — South America — — South America — — South Asia — — South Asia — — South Asia — — South Asia — —
Political & Grant Activity
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
Address 80 PINE Street 20TH FLR
New YORK, NY, 10005-175
Governance Voting board members 10
Independent members 9
Conflict-of-interest policy Yes
Whistleblower policy Yes
Doc-retention policy Yes
Audit committee Yes
990 reviewed by board Yes
Compensation practices Severance payments No
Equity-based comp No
Supplemental retirement plan No
Compensation committee Yes
Used comp survey Yes
Board approved comp Yes
Initial contract exception No
Public records
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.